A randomized, open-label, single-dose, 3-period crossover study to assess the effect of food on the pharmacokinetics of the final fixed dose combination formulation of COREG CR and lisinopril [carvedilol/lisinopril] in the fed and fasted state
Latest Information Update: 22 Aug 2023
At a glance
- Drugs Carvedilol/lisinopril (Primary)
- Indications Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 21 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 19 Nov 2007 New trial record.